These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6429807)

  • 21. Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
    Hauser I; Gisslinger H; Locker G; Elbl W; Kyrle PA; Pabinger I; Lechner K
    Wien Klin Wochenschr; 1993; 105(12):355-8. PubMed ID: 8333206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.
    Green D; Schuette PT; Wallace WH
    Arch Intern Med; 1980 Sep; 140(9):1232-5. PubMed ID: 6773487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factor VIII inhibitors].
    Albores Núñez MI; Pérez Llanderal JA; Telenti Vigón A
    Rev Clin Esp; 1968 Apr; 109(2):129-36. PubMed ID: 5739637
    [No Abstract]   [Full Text] [Related]  

  • 24. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission of acquired factor-VIII-inhibitor-induced bleeding.
    Ghosh ML
    Acta Haematol; 1980; 64(3):179-80. PubMed ID: 6778052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transient remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with a single infusion of factor VIII and cyclophosphamide (author's transl)].
    Kutsuzawa T; Nozaki H; Ichikawa Y; Nago T; Arimori S
    Rinsho Ketsueki; 1982 Feb; 23(2):173-9. PubMed ID: 6808195
    [No Abstract]   [Full Text] [Related]  

  • 27. [Factor VIII inhibitor in pancreatic cancer].
    Lauritsen K; Madsen PE
    Ugeskr Laeger; 1981 Jun; 143(24):1541. PubMed ID: 6792760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recombinant factor VIII-CVP therapy for acquired factor VIII inhibitors].
    Mori N; Toyokawa K; Teramura M; Masuda M; Motoji T
    Rinsho Ketsueki; 2007 Jul; 48(7):581-5. PubMed ID: 17695309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid].
    Kuboki T; Kudo T; Iwata N; Morimoto I
    Rinsho Ketsueki; 1999 Oct; 40(10):1087-92. PubMed ID: 10565226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired factor VIII inhibitor in a patient with malignant lymphoma.
    Wenz B; Friedman G
    Am J Med Sci; 1974 Nov; 268(5):295-9. PubMed ID: 4617504
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis.
    Merlini M; Moccia F; Delucchi M; Grillo G
    Ann Ital Med Int; 2005; 20(4):248-52. PubMed ID: 16610257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor.
    Gandini G; Franchini M; Manzato F; Lippi G; Aprili G
    Haematologica; 1999 Nov; 84(11):1054. PubMed ID: 10553173
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cryptogenic anti-8 inhibitor].
    Rochon M; Neemeh JA; Gosselin G; Long LA
    Union Med Can; 1971 Dec; 100(12):2353-6. PubMed ID: 5163028
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulating anticoagulant (antifactor 8 treated with immunosuppressive drugs.
    Sherman LA; Goldstein MA; Sise HS
    Thromb Diath Haemorrh; 1969 Apr; 21(2):249-58. PubMed ID: 5786668
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor.
    Pintado T; Taswell HF; Bowie EJ
    Blood; 1975 Oct; 46(4):535-41. PubMed ID: 1080677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double carriers of the factor V Leiden and prothrombin (FIIG20210A) mutations: a description of four cases.
    González Ordóñez AJ; Sánchez LM; Medina Rodríguez JM; Martínez Muñiz MA; Menéndez Caro JL; Alvarez MV
    Haematologica; 1999 Nov; 84(11):1054-6. PubMed ID: 10553174
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.